Steward Partners Investment Advisory, LLC Axsome Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$36.06 - $69.85 $154,553 - $299,377	-4,286 Reduced 95.24%	214 $10,000
Q4 2021 Feb 08, 2022	BUY	$30.7 - $43.36 $21,490 - $30,352	700 Added 18.42%	4,500 $170,000
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $73,667 - $252,562	3,700 Added 3700.0%	3,800 $125,000
Q2 2021 Aug 13, 2021	SELL	$50.63 - $73.5 $20,252 - $29,400	-400 Reduced 80.0%	100 $7,000
Q1 2021 May 14, 2021	BUY	$55.91 - $81.44 $27,955 - $40,720	500 New	500 $28,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.